Anticancer agent 265

Cat. No.: HY-I0450 Purity: 99.64%: FAQs
Data Sheet SDS COA Handling Instructions Technical Support

Anticancer agent 265 (compound 1) is an anticancer compound. Anticancer agent 265 exhibits in vitro anticancer activity against three human bone cancer lines, U2OS, Saos-2, and GC9811, with IC₅₀ values of 13.1, 11.7, and 14.6 μM, respectively.

For research use only. We do not sell to patients.

Anticancer agent 265 Chemical Structure

CAS No. : 184177-83-1

Size	Stock	Quantity
Free Sample (0.1 - 0.5 mg)	Apply Now
1 g	In-stock	Estimated Time of Arrival: December 31
5 g	In-stock	Estimated Time of Arrival: December 31
10 g	In-stock	Estimated Time of Arrival: December 31
25 g	In-stock	Estimated Time of Arrival: December 31
50 g	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

Molecular Weight

513.63

Formula

C₃₀H₃₅N₅O₃

CAS No.

184177-83-1

Appearance

Solid

Color

White to off-white

SMILES

O=C1N(C2=CC=C(N3CCN(C4=CC=C(O)C=C4)CC3)C=C2)C=NN1[C@@H](CC)[C@@H](OCC5=CC=CC=C5)C

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Purity & Documentation

Purity: 99.64%

Select Batch:

Data Sheet (266 KB) SDS (394 KB)

COA (248 KB) RP-HPLC (124 KB)

Handling Instructions (2659 KB)

References

[1]. G Lv, et al. Synthesis, crystal structure, anti-bone cancer activity and molecular docking investigations of the heterocyclic compound 1-((2S, 3S)-2-(benzyloxy) pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl) piperazin-1-yl) phenyl)-1H-1, 2, 4-triazol-5 (4H)-one. Journal of Structural Chemistry 60.7 (2019): 1173-1179.